Niacin fine‐tunes energy homeostasis through canonical GPR109A signaling
Open Access
- 31 December 2018
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 33 (4) , 4765-4779
Abstract
The incidence of overweight and obesity has become a global public health problem, constituting a major risk factor for numerous comorbidities. Despite tremendous efforts, effective pharmacological agents for the treatment of obesity are still limited. Here, we showed that in contrast to lactate receptor GPR81, niacin receptor GPR109A‐deficient mice had progressive weight gain and hepatic fat accumulation. Using high‐fat diet–induced mouse model of obesity, we demonstrated that niacin treatment apparently protected against obesity without affecting food intake in wild‐type mice but not in GPR109A‐deficient mice. Further investigation showed that niacin treatment led to a remarkable inhibition of hepatic de novo lipogenesis. Additionally, we demonstrated that niacin treatment triggered brown adipose tissue and/or white adipose tissue thermogenic activity via activation of GPR109A. Moreover, we observed that mice exposed to niacin exhibited a dramatic decrease in intestinal absorption of sterols and fatty acids. Taken together, our findings demonstrate that acting on GPR109A, niacin shows the potential to maintain energy homeostasis through multipathways, representing a potential approach to the treatment of obesity, diabetes and cardiovascular disease.—Ye, L., Cao, Z., Lai, X., Wang, W., Guo, Z., Yan, L., Wang, Y., Shi, Y., Zhou, N. Niacin fine‐tunes energy homeostasis through canonical GPR109A signaling. FASEB J. 33, 4765–4779 (2019). www.fasebj.orgKeywords
All Related Versions
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2012CB910402)
- National Natural Science Foundation of China (81173106, 31200621, 31771543)
- Natural Science Foundation of Zhejiang Province (LY15C050001)
This publication has 73 references indexed in Scilit:
- Liver fat reduction with niacin is influenced by DGAT-2 polymorphisms in hypertriglyceridemic patientsJournal of Lipid Research, 2012
- Anti-Inflammatory Effects of Nicotinic Acid in Human Monocytes Are Mediated by GPR109A Dependent MechanismsArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- International Union of Basic and Clinical Pharmacology. LXXXII: Nomenclature and Classification of Hydroxy-carboxylic Acid Receptors (GPR81, GPR109A, and GPR109B)Pharmacological Reviews, 2011
- Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cellsJournal of Clinical Investigation, 2011
- Modulation of HDL metabolism by the niacin receptor GPR109A in mouse hepatocytesBiochemical Pharmacology, 2010
- Niaspan treatment induces neuroprotection after strokeNeurobiology of Disease, 2010
- Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in MiceDiabetes, 2009
- Lipid metabolic enzymes: emerging drug targets for the treatment of obesityNature Reviews Drug Discovery, 2004
- Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia∗∗See Appendix for list of principal investigators, study sites, and laboratory sites.The American Journal of Cardiology, 1998
- Sustained Intracerebroventricular Infusion of Brain Fuels Reduces Body Weight and Food Intake in RatsScience, 1981